Hypothyroidism After TKIs for Cancer Linked to Longer Survival Hypothyroidism After TKIs for Cancer Linked to Longer Survival

Overt hypothyroidism after tyrosine kinase inhibitor (TKI) treatment for cancer is associated with a significant survival benefit, and the adverse effect may have prognostic value, say researchers.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news